Completed PHASE2 INTERVENTIONAL NCT00000282

Pemoline for Cocaine Abuse - 7

Pemoline for Cocaine Abuse

Sponsor: National Institute on Drug Abuse (NIDA)

Interventions Pemoline

Updated 5 times since 2017 Last updated: Dec 13, 2016 Started: Sep 30, 1994 Primary completion: Aug 31, 1999 Completion: Aug 31, 1999

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

This PHASE2 trial investigates Cocaine-Related Disorders and is currently completed. National Institute on Drug Abuse (NIDA) leads this study, which shows 5 recorded versions since 1994 — indicating limited longitudinal coverage. The change history captured here reflects the iterative nature of clinical trial conduct.

Status Flow

Change History

5 versions recorded

Sep 2024 — Present [monthly]

Completed PHASE2
Jul 2024 — Sep 2024 [monthly]

Completed PHASE2
Jan 2021 — Jul 2024 [monthly]

Completed PHASE2
Jun 2018 — Jan 2021 [monthly]

Completed PHASE2
Jan 2017 — Jun 2018 [monthly]

Completed PHASE2

First recorded

Sep 1994

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

National Institute on Drug Abuse (NIDA)
VA Connecticut Healthcare System
Yale University

Data source: Yale University

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• New Haven, United States